Covid-19 Impact on Obesity Surgery Devices Market, Global Research Reports 2020-2021
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Obesity Surgery Devices Quarterly Market Size Analysis
- 2.1 Obesity Surgery Devices Business Impact Assessment - COVID-19
- 2.1.1 Global Obesity Surgery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Obesity Surgery Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Obesity Surgery Devices Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Obesity Surgery Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Obesity Surgery Devices Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Obesity Surgery Devices Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Obesity Surgery Devices Market
- 3.5 Key Manufacturers Obesity Surgery Devices Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Obesity Surgery Devices Segments, By Type
- 4.1 Introduction
- 1.4.1 Intragastric Balloons
- 1.4.2 Gastric Electrical Stimulation
- 1.4.3 Gastric Bands
- 1.4.4 Staples
- 4.2 By Type, Global Obesity Surgery Devices Market Size, 2019-2021
- 4.2.1 By Type, Global Obesity Surgery Devices Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Obesity Surgery Devices Price, 2020-2021
5 Impact of Covid-19 on Obesity Surgery Devices Segments, By Application
- 5.1 Overview
- 5.5.1 Minimally Invasive Surgical
- 5.5.2 Non-invasive Surgical
- 5.2 By Application, Global Obesity Surgery Devices Market Size, 2019-2021
- 5.2.1 By Application, Global Obesity Surgery Devices Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Obesity Surgery Devices Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Johnson & Johnson
- 7.1.1 Johnson & Johnson Business Overview
- 7.1.2 Johnson & Johnson Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.1.3 Johnson & Johnson Obesity Surgery Devices Product Introduction
- 7.1.4 Johnson & Johnson Response to COVID-19 and Related Developments
- 7.2 Medtronic
- 7.2.1 Medtronic Business Overview
- 7.2.2 Medtronic Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.2.3 Medtronic Obesity Surgery Devices Product Introduction
- 7.2.4 Medtronic Response to COVID-19 and Related Developments
- 7.3 Apollo Endosurgery
- 7.3.1 Apollo Endosurgery Business Overview
- 7.3.2 Apollo Endosurgery Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.3.3 Apollo Endosurgery Obesity Surgery Devices Product Introduction
- 7.3.4 Apollo Endosurgery Response to COVID-19 and Related Developments
- 7.4 Mediflex Surgical Product
- 7.4.1 Mediflex Surgical Product Business Overview
- 7.4.2 Mediflex Surgical Product Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.4.3 Mediflex Surgical Product Obesity Surgery Devices Product Introduction
- 7.4.4 Mediflex Surgical Product Response to COVID-19 and Related Developments
- 7.5 TransEnterix
- 7.5.1 TransEnterix Business Overview
- 7.5.2 TransEnterix Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.5.3 TransEnterix Obesity Surgery Devices Product Introduction
- 7.5.4 TransEnterix Response to COVID-19 and Related Developments
- 7.6 Aspire Bariatrics
- 7.6.1 Aspire Bariatrics Business Overview
- 7.6.2 Aspire Bariatrics Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.6.3 Aspire Bariatrics Obesity Surgery Devices Product Introduction
- 7.6.4 Aspire Bariatrics Response to COVID-19 and Related Developments
- 7.7 Spatz FGIA
- 7.7.1 Spatz FGIA Business Overview
- 7.7.2 Spatz FGIA Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.7.3 Spatz FGIA Obesity Surgery Devices Product Introduction
- 7.7.4 Spatz FGIA Response to COVID-19 and Related Developments
- 7.8 MetaCure
- 7.8.1 MetaCure Business Overview
- 7.8.2 MetaCure Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.8.3 MetaCure Obesity Surgery Devices Product Introduction
- 7.8.4 MetaCure Response to COVID-19 and Related Developments
- 7.9 IntraPace
- 7.9.1 IntraPace Business Overview
- 7.9.2 IntraPace Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.9.3 IntraPace Obesity Surgery Devices Product Introduction
- 7.9.4 IntraPace Response to COVID-19 and Related Developments
- 7.10 Intuitive Surgical
- 7.10.1 Intuitive Surgical Business Overview
- 7.10.2 Intuitive Surgical Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.10.3 Intuitive Surgical Obesity Surgery Devices Product Introduction
- 7.10.4 Intuitive Surgical Response to COVID-19 and Related Developments
- 7.11 Allergan
- 7.11.1 Allergan Business Overview
- 7.11.2 Allergan Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.11.3 Allergan Obesity Surgery Devices Product Introduction
- 7.11.4 Allergan Response to COVID-19 and Related Developments
- 7.12 USGI Medical
- 7.12.1 USGI Medical Business Overview
- 7.12.2 USGI Medical Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.12.3 USGI Medical Obesity Surgery Devices Product Introduction
- 7.12.4 USGI Medical Response to COVID-19 and Related Developments
- 7.13 Semiled
- 7.13.1 Semiled Business Overview
- 7.13.2 Semiled Obesity Surgery Devices Quarterly Production and Revenue, 2020
- 7.13.3 Semiled Obesity Surgery Devices Product Introduction
- 7.13.4 Semiled Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Obesity Surgery Devices Supply Chain Analysis
- 8.1.1 Obesity Surgery Devices Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Obesity Surgery Devices Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Obesity Surgery Devices Distribution Channels
- 8.2.2 Covid-19 Impact on Obesity Surgery Devices Distribution Channels
- 8.2.3 Obesity Surgery Devices Distributors
- 8.3 Obesity Surgery Devices Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Obesity Surgery Devices, including the following market information:
Global Obesity Surgery Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Surgery Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Surgery Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Surgery Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Johnson & Johnson, Medtronic, Apollo Endosurgery, Mediflex Surgical Product, TransEnterix, Aspire Bariatrics, Spatz FGIA, MetaCure, IntraPace, Intuitive Surgical, Allergan, USGI Medical, Semiled, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Intragastric Balloons
Gastric Electrical Stimulation
Gastric Bands
Staples
Based on the Application:
Minimally Invasive Surgical
Non-invasive Surgical